Recent Updates
Recently added Catalysts
VTRS Positive Sentiment Score: 65/100

Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the company will participate in two upcoming healthcare conferences....

Key Takeaway: Viatris Inc. (Nasdaq: VTRS) announced its participation in the upcoming UBS Global Healthcare Conference and the Jefferies London Healthcare Conference. These events will feature live webcasts available for interested parties and will highlight the company's commitment to bridging generics and brand pharmaceuticals. Viatris aims to empower people worldwide by providing access to quality medicines across various health stages. The company's extensive portfolio and global supply chain positions it uniquely to address healthcare challenges.

Conference Participation Details

UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat

How to Access

Investors and the general public can listen to both sessions live at:

https://investor.viatris.com

Archived versions will be available following the live events for a limited time.

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris is participating in significant healthcare conferences which may enhance visibility.
  • The company aims to empower global healthcare needs through its extensive portfolio.
  • Viatris has a mission focused on improving health access for 1 billion patients annually.

Full Press Release Details

PITTSBURGH , Oct. 29, 2024 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS ), a global healthcare company, today announced that the company will participate in two upcoming healthcare conferences.
Details of the presentations can be found below:
UBS Global Healthcare Conference
Jeffries London Healthcare Conference
Interested parties can access live webcasts of both events at investor.viatris.com . An archived version also will be available following the live event and can be accessed at the same location for a limited time.
About Viatris Viatris Inc . (NASDAQ: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X (formerly Twitter).
SOURCE Viatris Inc.

21 %

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

What healthcare conferences will Viatris participate in?

Viatris will participate in the UBS Global Healthcare Conference and the Jeffries London Healthcare Conference.

Where can I access the webcasts of Viatris' events?

Live webcasts of the events can be accessed at investor.viatris.com.

When will the archived webcasts be available?

Archived versions will be available for a limited time after the live events.

What is the mission of Viatris?

Viatris aims to empower people globally to live healthier at every life stage.

How many patients does Viatris provide medicine to annually?

Viatris supplies high-quality medicines to approximately 1 billion patients each year.

Last updated: Oct 29, 2024